Atai Beckley N.V. (B72) Stock Forecast & Price Target

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

B72 Analyst Ratings

Hold

1 Buy

11 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Atai

Beckley N.V.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

B72 Stock 12 Month Forecast

Average Price Target

€6.60

▲(2.34% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Atai Beckley N.V. in the last 3 months. The average price target is €6.60 with a high forecast of €6.87 and a low forecast of €6.39. The average price target represents a 2.34% change from the last price of €6.45.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","4":"€4","7":"€7","2.5":"€2.5","5.5":"€5.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6.86688208,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€6.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.6007903994,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€6.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.394783937,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€6.39</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.5,4,5.5,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.25,6.297452467692308,6.344904935384616,6.3923574030769235,6.43980987076923,6.487262338461538,6.534714806153846,6.582167273846154,6.629619741538462,6.6770722092307695,6.724524676923076,6.771977144615384,6.819429612307692,{"y":6.86688208,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.25,6.2769838768769235,6.303967753753846,6.33095163063077,6.357935507507692,6.384919384384616,6.411903261261538,6.438887138138462,6.465871015015384,6.492854891892308,6.5198387687692305,6.546822645646154,6.573806522523077,{"y":6.6007903994,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.25,6.261137225923077,6.272274451846154,6.283411677769231,6.2945489036923075,6.305686129615385,6.316823355538461,6.3279605814615385,6.339097807384615,6.350235033307692,6.361372259230769,6.372509485153846,6.383646711076922,{"y":6.394783937,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.434,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.998,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.448,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.016,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.231,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.426,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.426,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.9,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.16,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.48,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.92,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.56,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€6.87

Average Price Target€6.60

Lowest Price Target€6.39

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Patrick Trucchio

H.C. Wainwright

€6.44

Hold

-0.19%

Downside

Reiterated

08/21/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (NASDAQ: ATAI), InspireMD (NASDAQ: NSPR) and Silexion Therapeutics (NASDAQ: SLXN)

Jay Olson

Oppenheimer

―

Hold

―

Downgraded

08/17/26

AtaiBeckley downgraded to Perform from Outperform at OppenheimerAtaiBeckley downgraded to Perform from Outperform at Oppenheimer

David Hoang

Deutsche Bank

€10.3→€6.87

Hold

6.46%

Upside

Downgraded

08/12/26

Analysts Offer Insights on Healthcare Companies: Genmab (NASDAQ: GMAB), Definitive Healthcare Corp (NASDAQ: DH) and Atai Beckley N.V. (NASDAQ: ATAI)

Harry Gillis

Berenberg Bank

€12.02→€6.39

Hold

-0.86%

Downside

Downgraded

07/20/26

AtaiBeckley downgraded to Hold from Buy at BerenbergAtaiBeckley downgraded to Hold from Buy at Berenberg

Ritu Baral

TD Cowen

―

Hold

―

Downgraded

07/17/26

AtaiBeckley downgraded to Hold from Buy at TD CowenAtaiBeckley downgraded to Hold from Buy at TD Cowen

Andrew Tsai

Jefferies

€6.44

Hold

-0.19%

Downside

Downgraded

07/17/26

AtaiBeckley downgraded to Hold from Buy at JefferiesAtaiBeckley downgraded to Hold from Buy at Jefferies

Sumant Kulkarni

Canaccord Genuity

€14.59→€6.87

Buy

6.46%

Upside

Reiterated

07/17/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (NASDAQ: ATAI), Alnylam Pharma (NASDAQ: ALNY) and Elevance Health (NYSE: ELV)

Michael Okunewitch

Maxim Group

―

Hold

―

Downgraded

07/17/26

AtaiBeckley downgraded to Hold from Buy at MaximAtaiBeckley downgraded to Hold from Buy at Maxim

Ami Fadia

Needham

―

Hold

―

Downgraded

07/16/26

AtaiBeckley downgraded to Hold from Buy at NeedhamAtaiBeckley downgraded to Hold from Buy at Needham

Justin Walsh

JonesTrading

―

Hold

―

Downgraded

07/16/26

JonesTrading downgrades Atai Beckley N.V. (ATAI) to a Hold

Eddie Hickman

Guggenheim

―

Hold

―

Downgraded

07/16/26

AtaiBeckley downgraded to Neutral from Buy at GuggenheimAtaiBeckley downgraded to Neutral from Buy at Guggenheim

Pete Stavropoulos

Cantor Fitzgerald

―

Hold

―

Downgraded

07/16/26

AtaiBeckley downgraded to Neutral from Overweight at Cantor FitzgeraldAtaiBeckley downgraded to Neutral from Overweight at Cantor Fitzgerald

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Patrick Trucchio

H.C. Wainwright

€6.44

Hold

-0.19%

Downside

Reiterated

08/21/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (NASDAQ: ATAI), InspireMD (NASDAQ: NSPR) and Silexion Therapeutics (NASDAQ: SLXN)

Jay Olson

Oppenheimer

―

Hold

―

Downgraded

08/17/26

AtaiBeckley downgraded to Perform from Outperform at OppenheimerAtaiBeckley downgraded to Perform from Outperform at Oppenheimer

David Hoang

Deutsche Bank

€10.3→€6.87

Hold

6.46%

Upside

Downgraded

08/12/26

Analysts Offer Insights on Healthcare Companies: Genmab (NASDAQ: GMAB), Definitive Healthcare Corp (NASDAQ: DH) and Atai Beckley N.V. (NASDAQ: ATAI)

Harry Gillis

Berenberg Bank

€12.02→€6.39

Hold

-0.86%

Downside

Downgraded

07/20/26

AtaiBeckley downgraded to Hold from Buy at BerenbergAtaiBeckley downgraded to Hold from Buy at Berenberg

Ritu Baral

TD Cowen

―

Hold

―

Downgraded

07/17/26

AtaiBeckley downgraded to Hold from Buy at TD CowenAtaiBeckley downgraded to Hold from Buy at TD Cowen

Andrew Tsai

Jefferies

€6.44

Hold

-0.19%

Downside

Downgraded

07/17/26

AtaiBeckley downgraded to Hold from Buy at JefferiesAtaiBeckley downgraded to Hold from Buy at Jefferies

Sumant Kulkarni

Canaccord Genuity

€14.59→€6.87

Buy

6.46%

Upside

Reiterated

07/17/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (NASDAQ: ATAI), Alnylam Pharma (NASDAQ: ALNY) and Elevance Health (NYSE: ELV)

Michael Okunewitch

Maxim Group

―

Hold

―

Downgraded

07/17/26

AtaiBeckley downgraded to Hold from Buy at MaximAtaiBeckley downgraded to Hold from Buy at Maxim

Ami Fadia

Needham

―

Hold

―

Downgraded

07/16/26

AtaiBeckley downgraded to Hold from Buy at NeedhamAtaiBeckley downgraded to Hold from Buy at Needham

Justin Walsh

JonesTrading

―

Hold

―

Downgraded

07/16/26

JonesTrading downgrades Atai Beckley N.V. (ATAI) to a Hold

Eddie Hickman

Guggenheim

―

Hold

―

Downgraded

07/16/26

AtaiBeckley downgraded to Neutral from Buy at GuggenheimAtaiBeckley downgraded to Neutral from Buy at Guggenheim

Pete Stavropoulos

Cantor Fitzgerald

―

Hold

―

Downgraded

07/16/26

AtaiBeckley downgraded to Neutral from Overweight at Cantor FitzgeraldAtaiBeckley downgraded to Neutral from Overweight at Cantor Fitzgerald

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Atai Beckley N.V.

3 Months

Sumant KulkarniCanaccord Genuity

Success Rate

11/21 ratings generated profit

Average Return

+13.96%

Copying Sumant Kulkarni's trades and holding each position for 3 Months would result in 52.38% of your transactions generating a profit, with an average return of +13.96% per trade.

1 Year

Sumant KulkarniCanaccord Genuity

Success Rate

15/21 ratings generated profit

Average Return

+49.67%

Copying Sumant Kulkarni's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +49.67% per trade.

2 Years

Sumant KulkarniCanaccord Genuity

Success Rate

17/21 ratings generated profit

Average Return

+105.69%

Copying Sumant Kulkarni's trades and holding each position for 2 Years would result in 80.95% of your transactions generating a profit, with an average return of +105.69% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

B72 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, B72 has received 9 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. B72 average Analyst price target in the past 3 months is 6.60.

Each month's total comprises the sum of three months' worth of ratings.

B72 Financial Forecast

B72 Earnings Forecast

The previous quarter’s earnings for B72 were -€0.08.

B72 Sales Forecast

The previous quarter’s earnings for B72 were €1.47M.

B72 Stock Forecast FAQ

What is DE:B72’s average 12-month price target, according to analysts?

Based on analyst ratings, Atai Beckley N.V.’s 12-month average price target is 6.60.

What is DE:B72’s upside potential, based on the analysts’ average price target?

Atai Beckley N.V. has 2.34% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Atai Beckley N.V. a Buy, Sell or Hold?

Atai Beckley N.V. has a consensus rating of Hold, which is based on 1 buy ratings, 11 hold ratings and 0 sell ratings.

What is Atai Beckley N.V.’s share price target?

The average share price target for Atai Beckley N.V. is 6.60. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €6.87 ,and the lowest forecast is €6.39. The average share price target represents 2.34% Increase from the current price of €6.45.

What do analysts say about Atai Beckley N.V.?

Atai Beckley N.V.’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Atai Beckley N.V.?

To buy shares of DE:B72, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Atai Beckley N.V. (B72) Stock Forecast & Price Target

B72 Analyst Ratings

B72 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Atai Beckley N.V.

B72 Analyst Recommendation Trends

B72 Financial Forecast

B72 Earnings Forecast

B72 Sales Forecast

B72 Stock Forecast FAQ

Detailed List of Analyst Forecasts